Updated:
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001718852, and its reported...
Overview
Prometheus Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001718852, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-02-28, it reported annual revenue of USD 6,809,000; net income of USD -141,752,000; total assets of USD 740,773,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Prometheus Biosciences, Inc.
- Former names in filing history
- Precision IBD, Inc. (2017-10-10 to 2019-07-15)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001718852
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $6.8M | -$141.8M | $740.8M | $292.4M | -$123.3M | |
| FY2021USD | $3.1M | -$90.2M | $267.8M | $257.3M | -$63.5M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Prometheus Biosciences, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.